Harbinger Health Establishes RESOLVE™ as a New Category for Cancer Detection

Announces $100M financing to develop a portfolio of multi-cancer tests designed to reduce diagnostic uncertainty and delays Financing also supports further development of the Harbinger HX platform and evidence generation for a portfolio of category-defining solutions for cancer detection...